Not applicableUnknownNCT03489915What this trial is testingCorrelation Between the Visual Acuity & the OCT Pattern of Macular Edema Secondary to RVOWho this might be right forRetinal Vein Occlusion Assiut University 30
Not applicableStudy completedNCT01571557What this trial is testingA Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)Who this might be right forMacular EdemaRetinal Vein Occlusion Allergan 573
Testing effectiveness (Phase 2)UnknownNCT01809236What this trial is testingEfficacy and Safety of Conbercept in Macular Edema Secondary to Retinal Vein OcclusionWho this might be right forRetinal Vein Occlusion Chengdu Kanghong Biotech Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT00407355What this trial is testingRanibizumab (Lucentis) for Macular Edema Secondary to Vein OcclusionsWho this might be right forMacular EdemaRetinal Vein Occlusion Peter A Campochiaro, MD 40
Large-scale testing (Phase 3)Study completedNCT05850520What this trial is testingLearn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion)Who this might be right forMacular Edema Secondary to Retinal Vein Occlusion Bayer 892
Post-approval studies (Phase 4)UnknownNCT04062370What this trial is testingRanibizumab Treatment for Macular Edema Secondary to Retinal Vein OcclusionWho this might be right forRetinal Vein OcclusionTreatmentPhotocoagulation Burn to Retina+1 more Sun Yat-sen University 100
Not applicableStudy completedNCT01442064What this trial is testingAn Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)Who this might be right forMacular EdemaRetinal Vein Occlusion Genentech, Inc. 608
Not applicableStudy completedNCT05345808What this trial is testingEfficacy of Formulated Posterior Sub Tenon Triamcinolone in Macular Edema Secondary to Non-Ischemic Retinal Vein OcclusionsWho this might be right forRetinal Vein Occlusion Al-Azhar University 46
Post-approval studies (Phase 4)Study completedNCT03908307What this trial is testingEvaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in ChinaWho this might be right forMacular EdemaRetinal Vein Occlusion Allergan 150
Testing effectiveness (Phase 2)Study completedNCT06176963What this trial is testingEvaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVOWho this might be right forNeovascular Age-related Macular DegenerationMacular EdemaRetinal Vein Occlusion Samsung Bioepis Co., Ltd. 34
Large-scale testing (Phase 3)Study completedNCT00485836What this trial is testingThe Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)Who this might be right forMacular EdemaRetinal Vein Occlusion Genentech, Inc. 392
Testing effectiveness (Phase 2)Ended earlyNCT00770770What this trial is testingFluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in RetinaWho this might be right forMacular EdemaRetinal Vein Occlusion Alimera Sciences 20
Early research (Phase 1)Study completedNCT01028248What this trial is testingLucentis for Macular Edema Associated With Central Retinal Vein OcclusionWho this might be right forCentral Retinal Vein Occlusion California Retina Consultants 20
Post-approval studies (Phase 4)Study completedNCT02800642What this trial is testingEvaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVOWho this might be right forCentral Retinal Vein Occlusion Bayer 162
Post-approval studies (Phase 4)UnknownNCT03405376What this trial is testingProspective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein OcclusionWho this might be right forBranch Retinal Vein Occlusion With Macular Edema Yeungnam University College of Medicine 49
Post-approval studies (Phase 4)Study completedNCT02953938What this trial is testingStudy to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and SafetyWho this might be right forMacular Edema Secondary to Branch Retinal Vein Occlusion (BRVO) Novartis Pharmaceuticals 59
Not applicableStudy completedNCT00379795What this trial is testingAn Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVOWho this might be right forChoroidal Neovascularization, Age-related Macular Degeneration Genentech, Inc. 853
Not applicableUnknownNCT01581151What this trial is testingOzurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein OcclusionWho this might be right forRetinal Vein Occlusion Brian Burke, MPH 30
Testing effectiveness (Phase 2)Study completedNCT00088283What this trial is testingPegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)Who this might be right forRetinal Vein Occlusion Eyetech Pharmaceuticals 90
Large-scale testing (Phase 3)Study completedNCT03223714What this trial is testingConbercept Ophthalmic Injection for Patients of Central Retinal Vein OcclusionWho this might be right forMacular EdemaCentral Retinal Vein Occlusion Chengdu Kanghong Biotech Co., Ltd. 242